CEO SUMMARY: Medicare/Medicaid regulators get serious about laboratory billing and reimbursement practices. Industry observers say it represents a major shift and will have immense financial and operational impact on every clinical laboratory in the United States.
FOLLOWING YEARS of “benign neglect” toward Medicare billing practices, regulators will now scrutinize laboratory reimbursement activities with full vigor.
Subscriber-Only Content. Please Log In.
You are trying to access subscribers-only content. If you are a subscriber, please log in.
If you are not a subscriber, click here to see subscription offers.
Subscribers will have instant access to the Dark Report library, 1997-the present, giving you the most convenient, accessible archive available in laboratory business intelligence today!
To read our FREE article previews, go to The Dark Report Insider.